Build vs. Buy a Medical Device Cloud in the GenAI Era: A Decision Guide

Executive Summary

GenAI coding tools have made building a medical device cloud in-house look easier than ever. They have not made it cheaper to certify, operate, or maintain. Based on actual client engagements at BioT, a DIY medical device cloud costs $2,114,875 over three years versus $438,100 on a certified platform, and the certification timeline alone delays revenue by 18 to 24 months. AI-assisted development changes where you should spend engineering time. It does not change the build-vs-buy math for regulated infrastructure.

Last updated: July 2026

Why Did the Build vs. Buy Question Change in 2025-2026?

Two years ago, "should we build our own device cloud" was a resourcing question. Today it is an AI question. CTOs watch a coding agent scaffold a backend in an afternoon and conclude that the build side of the equation has collapsed. They are half right.

GenAI genuinely accelerates: frontend applications, API integrations, data models, documentation drafts, test scaffolding. In our own deployments, AI agents generate complete portal applications from API specs in days.

GenAI does not accelerate: HITRUST r2 audits, SOC 2 Type 2 observation periods, FDA cybersecurity documentation, penetration test remediation, 24/7 incident response, multi-tenant PHI isolation, post-market surveillance. These are earned through operating history and third-party audits. No prompt shortens an 18-24 month certification observation window.

Clouds succeed because of the infrastructure they rest upon. GenAI changed how fast you can write code. It did not change what the infrastructure underneath must prove.

How Much Does It Cost to Build a Medical Device Cloud in the GenAI Era?

Build it wrong, and your cloud becomes a nightmare. Months of development turn into years. Security gaps show up faster than you can patch them. Global compliance becomes an ongoing struggle. And maintenance runs around the clock just to keep things running.

That nightmare has a price tag. From BioT client engagement data across development, clinical study, and commercialization phases:

• Year 1 (Development): $736K DIY versus $138K on BioT
• Year 2 (Studies): $627K versus $123K
• Year 3 (Commercialization): $752K versus $176K
• Total 3-year OpEx: $2,114,875 versus $438,100
• Certifications (HITRUST, SOC 2, ISO, pen tests, SBOM): $771K versus $0, inherited from the platform
• Specialist FTEs (security, cloud ops, BI): $1,271,875 versus $203,000
• Time until sellable to US health systems: 18-24 months versus day one

‍

The GenAI counterargument says AI cuts the development line items. Grant it generously: assume AI halves DIY development cost. The certification costs ($771K) and specialist operations headcount do not move, because they are not code-writing activities. The three-year gap stays above $1.2M, and the certification delay stays untouched. The full line-item breakdown is in our 3-year cost comparison.

What Can AI Coding Tools Actually Build?

• Frontend portals and dashboards: yes. Well-defined patterns, fast iteration, and human review catches errors.
• API integrations and service layers: yes. Generated reliably from clear API specs.
• Regulatory document drafts (SRS, STD, user manuals): partially. AI drafts, QA/RA must verify and sign.
• Backend business logic: risky. Possible, but you own validation, maintenance, and liability.
• Certified infrastructure (HITRUST, SOC 2, ISO 27001): no. Certifications require audits and 18-24 months of operating evidence.
• Multi-tenant PHI isolation and ABAC: no. One misconfigured rule is a reportable breach.
• Device lifecycle (certificates, OTA updates, telemetry at scale): no. This needs proven infrastructure, not generated endpoints.
• 24/7 monitoring, incident response, and threat management: no. This is an operations capability, not a code artifact.

Build it right, and the cloud becomes your superpower. The right split: a certified platform for the regulated layer underneath, and GenAI pointed at the layers where it is genuinely strong. That combination is how BioT customers go from questionnaire to working product in weeks, not months.

"The transition was achieved in a matter of months, not years, freeing the NeuroCatch software team from the burden of cloud development and allowing for faster deployment of new features and services."
John Temprile, Director of Software, NeuroCatch

When Is Building In-House the Right Call?

An honest framework includes the cases where a platform loses. Building your own cloud makes sense when:

• Your cloud is the product. If your core IP is the data platform itself, not the device or therapy, owning the infrastructure may justify the cost.
• You already run a certified cloud business. If your company holds HITRUST or equivalent certifications and staffs a 24/7 security operation for other products, the marginal cost of building drops sharply.
• You have no US health system or EU hospital sales motion. If your device never touches hospital procurement or PHI, the certification burden that drives the cost gap mostly disappears.
• You need extreme customization and have no time pressure. If time to revenue does not matter and your requirements genuinely cannot fit any platform, building buys unlimited flexibility at 3-5x the cost.

Most venture-backed device makers match none of these. Their differentiation is the device, algorithm, or therapy. Their runway does not absorb a two-year certification detour.

How Should You Decide? Three Questions

You are a medical technology company. Not a cloud infrastructure company. Answer three questions.

1. Will you sell into US health systems or EU hospitals? If yes, you need HITRUST r2, SOC 2, and ISO 27001 before procurement advances. Platform inheritance saves $771K and 18 to 24 months.
2. Is your cloud backend your competitive differentiation? If no, every engineer-month spent on infrastructure is a month not spent on your device. FTE savings on a platform: 84%.
3. Do you believe GenAI closes the gap? Test it. Ask your team which certification an AI agent can pass on your behalf. The answer defines the layer you should not build.

"BioT was an accelerator. We achieved 'time to certification' quickly enabling us to generate revenue 18-24 months sooner."
Jessica Liberatore, Head of Product, Bloomlife

Frequently Asked Questions

Can you vibe-code a medical device cloud?

You can vibe-code the application layer on top of one. Frontends, integrations, and documentation drafts generate well from a structured platform's API specs. Certified infrastructure, compliance processes, and multi-tenant data isolation cannot be generated, because they are audited operating capabilities, not code.

How much does it cost to build a medical device cloud in-house?

Based on BioT client engagement data, $2,114,875 over three years covering development, clinical studies, and commercialization, including $771K in direct certification costs and $1.27M in specialist engineering.

How long until an in-house cloud can pass hospital procurement?

Typically 18 to 24 months, because SOC 2 Type 2 and HITRUST r2 require documented operating history before certification is granted.

Does using a platform lock in my data?

On BioT, the platform deploys on your cloud account. You own and control all data at all times.

The Bottom Line

GenAI made it faster to write code. It did not make it faster to earn certifications, operate securely, or pass hospital procurement. Building cloud infrastructure from scratch remains a $1.7M distraction that delays revenue by up to two years, with or without AI assistance.

Your time and resources should go to new innovations for your patients and their caregivers. Not to building and rebuilding the plumbing for your cloud. If you want your cloud journey to succeed, don't build a plane from scratch. Buy one.

‍